BRAF c.109T>G ;(p.S37A)

Variant ID: 7-140624395-A-C

NM_004333.4(BRAF):c.109T>G;(p.S37A)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Reconciling the Biological and Transcriptional Variability of Hepatoblastoma with Its Mutational Uniformity.

Cancers
Prochownik, Edward V EV
Publication Date: 2021-04-21

Variant appearance in text: BRAF: S37A
PubMed Link: 33919162
Variant Present in the following documents:
  • Main text
View BVdb publication page



Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium.

Nature Communications
Brandt, Raphael R; Sell, Thomas T; Lüthen, Mareen M; Uhlitz, Florian F; Klinger, Bertram B; Riemer, Pamela P; Giesecke-Thiel, Claudia C; Schulze, Silvia S; El-Shimy, Ismail Amr IA; Kunkel, Desiree D; Fauler, Beatrix B; Mielke, Thorsten T; Mages, Norbert N; Herrmann, Bernhard G BG; Sers, Christine C; Blüthgen, Nils N; Morkel, Markus M
Publication Date: 2019-07-02

Variant appearance in text: BRAF: S37A
PubMed Link: 31266962
Variant Present in the following documents:
  • Main text
  • 41467_2019_Article_10954.pdf
View BVdb publication page



SMK-17, a MEK1/2-specific inhibitor, selectively induces apoptosis in β-catenin-mutated tumors.

Scientific Reports
Kiga, Masaki M; Nakayama, Ayako A; Shikata, Yuki Y; Sasazawa, Yukiko Y; Murakami, Ryo R; Nakanishi, Toshiyuki T; Tashiro, Etsu E; Imoto, Masaya M
Publication Date: 2015-02-02

Variant appearance in text: BRAF: S37A
PubMed Link: 25640451
Variant Present in the following documents:
  • Main text
  • srep08155.pdf
View BVdb publication page



Colon cancer cells adopt an invasive phenotype without mesenchymal transition in 3-D but not 2-D culture upon combined stimulation with EGF and crypt growth factors.

Bmc Cancer
Ludwig, Kirsten K; Tse, Edison S ES; Wang, Jean Yj JY
Publication Date: 2013-05-02

Variant appearance in text: BRAF: S37A
PubMed Link: 23638973
Variant Present in the following documents:
  • Main text
View BVdb publication page



β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.

Cell
Rosenbluh, Joseph J; Nijhawan, Deepak D; Cox, Andrew G AG; Li, Xingnan X; Neal, James T JT; Schafer, Eric J EJ; Zack, Travis I TI; Wang, Xiaoxing X; Tsherniak, Aviad A; Schinzel, Anna C AC; Shao, Diane D DD; Schumacher, Steven E SE; Weir, Barbara A BA; Vazquez, Francisca F; Cowley, Glenn S GS; Root, David E DE; Mesirov, Jill P JP; Beroukhim, Rameen R; Kuo, Calvin J CJ; Goessling, Wolfram W; Hahn, William C WC
Publication Date: 2012-12-21

Variant appearance in text: BRAF: S37A
PubMed Link: 23245941
Variant Present in the following documents:
  • Main text
View BVdb publication page



Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development.

Genes & Development
Delmas, Véronique V; Beermann, Friedrich F; Martinozzi, Silvia S; Carreira, Suzanne S; Ackermann, Julien J; Kumasaka, Mayuko M; Denat, Laurence L; Goodall, Jane J; Luciani, Flavie F; Viros, Amaya A; Demirkan, Nese N; Bastian, Boris C BC; Goding, Colin R CR; Larue, Lionel L
Publication Date: 2007-11-15

Variant appearance in text: BRAF: S37A
PubMed Link: 18006687
Variant Present in the following documents:
  • Main text
View BVdb publication page